CCKA and CCKB Receptors Are Expressed in Small Cell Lung Cancer Lines and Mediate Ca2+ Mobilization and Clonal Growth
Overview
Authors
Affiliations
Gastrin, cholecystokinin (CCK), and CCK-related peptides comprise a hormonal family characterized by an identical carboxy-terminal amino acid sequence, a domain critical for receptor binding. The addition of gastrin to small cell lung cancer (SCLC) cells causes a rapid and transient increase in the intracellular concentration of calcium ([Ca2+]i). Furthermore, gastrin acts as a direct growth factor through CCKB/gastrin receptors. We report here that the expression of the mRNA coding for CCKB/gastrin receptors correlates with the responsiveness of SCLC cells to gastrin in terms of Ca2+ mobilization and stimulation of clonal growth in semisolid medium. The GLC19 SCLC cell line had no detectable expression of CCKB/gastrin receptor mRNA. Accordingly, gastrin (1-100 nM) did not cause any measurable increase in [Ca2+]i. In contrast, the addition of cholecystokinin residues 26-33 (CCK-8) caused a rapid and transient increase in [Ca2+]i in this cell line. CCK-8 mobilized Ca2+ in a dose-dependent manner in the nanomolar range (half-maximal stimulatory concentration = 12 nM). Furthermore, the selective CCKA antagonist CAM-1481 inhibited the increase in [Ca2+]i induced by CCK-8 (half-maximal inhibitory concentration = 3 nM) in GLC19 but not in H510 cells. The selective CCKB/gastrin antagonist blocked the increase in [Ca2+]i induced by CCK-8 (half-maximal inhibitory concentration = 80 pM) in H510 but not in GLC19 cells. Thus, the effects of CCK-8 are mediated through CCKA receptors in GLC19 cells and via CCKB/gastrin receptors in H510 cells. CCK-8 markedly stimulated colony formation in GLC19 cells in a dose-dependent manner in the nanomolar range, whereas over the same concentration range, gastrin had no effect on clonal growth. CAM-1481 inhibited the CCK-stimulated colony formation in GLC19 but not in H510 cells. Our results show, for the first time, that CCKA receptors can mediate Ca2+ mobilization and growth in SCLC cells and that SCLC cells express two distinct functional CCK receptor subtypes.
Verona M, Rubagotti S, Croci S, Sarpaki S, Borgna F, Tosato M Molecules. 2021; 26(4).
PMID: 33572353 PMC: 7916174. DOI: 10.3390/molecules26040918.
Kaloudi A, Kanellopoulos P, Radolf T, Chepurny O, Rouchota M, Loudos G Mol Pharm. 2020; 17(8):3116-3128.
PMID: 32568549 PMC: 7429258. DOI: 10.1021/acs.molpharmaceut.0c00605.
Kaelberer M, Caceres A, Jordt S Am J Physiol Lung Cell Mol Physiol. 2020; 318(5):L953-L964.
PMID: 32159971 PMC: 7272742. DOI: 10.1152/ajplung.00403.2019.
Khan M, Huang T, Lin C, Wu J, Fan B, Bian Z Oncotarget. 2017; 8(61):104615-104637.
PMID: 29262666 PMC: 5732832. DOI: 10.18632/oncotarget.18403.
Yu B, Lv X, Su L, Li J, Yu Y, Gu Q PLoS One. 2016; 11(8):e0158961.
PMID: 27518872 PMC: 4982598. DOI: 10.1371/journal.pone.0158961.